Literature DB >> 8810685

Joint assessment in rheumatoid arthritis.

D L Scott1, D A Houssien.   

Abstract

Determining the number of swollen joints and tender joints is a key component in the clinical assessment of rheumatoid arthritis (RA). There have been a series of investigations carried out in the last decade, which have defined the best ways to measure joint inflammation and have identified which joints should be evaluated. There is not complete agreement on the optimal joint count, but two approaches are widely used. These comprise counting either 66/68 or 28 joints. The main difference is that the 28-joint count excludes the joints in the feet. Both methods give similar information and are reproducible and valid. Tenderness and swelling should be measured separately. There are advantages and disadvantages associated with using the 28-joint count. It has the benefit of simplicity and takes less time, although some potentially relevant clinical information about the feet may be lost. There is general agreement that grading the severity of individual joint involvement is of limited advantage. Using weighted joint counts is also not widely accepted. Finally there is growing recognition of the need for training in the methods of assessing joints and the importance of international standardization. Joint counts are a component of the core clinical data set for RA and will continue to play a key role in the foreseeable future.

Entities:  

Mesh:

Year:  1996        PMID: 8810685     DOI: 10.1093/rheumatology/35.suppl_2.14

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  10 in total

1.  Most visits of most patients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count.

Authors:  T Pincus; O G Segurado
Journal:  Ann Rheum Dis       Date:  2005-11-16       Impact factor: 19.103

2.  Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteria.

Authors:  Shadi H Shahouri; Kaleb Michaud; Ted R Mikuls; Liron Caplan; Timothy S Shaver; James D Anderson; David N Weidensaul; Ruth E Busch; Shirley Wang; Frederick Wolfe
Journal:  Arthritis Rheum       Date:  2011-11

3.  74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis.

Authors:  Isabelle Delabaye; Filip De Keyser
Journal:  Arthritis Res Ther       Date:  2010-06-22       Impact factor: 5.156

4.  Double-blinded infliximab dose escalation in patients with rheumatoid arthritis.

Authors:  Mahboob U Rahman; Ingrid Strusberg; Piet Geusens; Alberto Berman; David Yocum; Daniel Baker; Carrie Wagner; John Han; Rene Westhovens
Journal:  Ann Rheum Dis       Date:  2007-03-28       Impact factor: 19.103

5.  Patient demographics and disease variables correlate with distinct cytokine patterns in mitogen-stimulated peripheral blood mononuclear cells from rheumatoid arthritis patients.

Authors:  Sukhbir Singh Uppal; Raj Raghupathy; Sawsan J Hayat; Rafiqul Islam Chowdhury; Mini Abraham; Parvez Rawoot
Journal:  Rheumatol Int       Date:  2007-11-29       Impact factor: 2.631

6.  The TT genotype of the STAT4 rs7574865 polymorphism is associated with high disease activity and disability in patients with early arthritis.

Authors:  Amalia Lamana; Alejandro Balsa; Blanca Rueda; Ana M Ortiz; Laura Nuño; Maria Eugenia Miranda-Carus; Maria F Gonzalez-Escribano; Miguel A Lopez-Nevot; Dora Pascual-Salcedo; Javier Martin; Isidoro González-Álvaro
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

7.  Association between arthritis treatments and ovarian reserve: a prospective study.

Authors:  Vinita M Alexander; Jillian Ashley-Martin; Joan K Riley; Amber R Cooper; Valerie S Ratts; Emily S Jungheim
Journal:  Reprod Biomed Online       Date:  2021-03-31       Impact factor: 4.567

8.  Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including HandScan (Optical Spectral Transmission) Scores.

Authors:  Maxime M A Verhoeven; Antonius A A Westgeest; Andreas Schwarting; Johannes W G Jacobs; Caroline Heller; Jacob M van Laar; Floris P J G Lafeber; Janneke Tekstra; Konstantinos Triantafyllias; Paco M J Welsing
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-06-18       Impact factor: 5.178

Review 9.  Modern psychometrics applied in rheumatology--a systematic review.

Authors:  Liseth Siemons; Peter M Ten Klooster; Erik Taal; Cees Aw Glas; Mart Afj Van de Laar
Journal:  BMC Musculoskelet Disord       Date:  2012-10-31       Impact factor: 2.362

10.  Effects of Aerobic and Resistance Exercise in Older Adults With Rheumatoid Arthritis: A Randomized Controlled Trial.

Authors:  Elvira Lange; Daniel Kucharski; Sara Svedlund; Karin Svensson; Gunhild Bertholds; Inger Gjertsson; Kaisa Mannerkorpi
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-01       Impact factor: 4.794

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.